Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development

R. A. Wirtz, Fidel P Zavala, Y. Charoenvit, G. H. Campbell, T. R. Burkot, I. Schneider, K. M. Esser, R. L. Beaudoin, R. G. Andre

Research output: Contribution to journalArticle

Abstract

Ten monoclonal antibodies developed against Plasmodium falciparum sporozoites at four institutions were evaluated for use in an enzyme-linked immunosorbent assay (ELISA). Four of the antibodies were eliminated because of their low sensitivity or requirement for high concentrations of capture antibody, while an additional four were rejected because they exhibited cross-reactivity with P. berghei sporozoites. Of the two remaining monoclonal antibodies, that designated 2A10 had the highest sensitivity, a requirement for lower concentrations of capture antibody, and had been tested successfully against sporozoites from a wider range of geographical areas than the others. Use of this monoclonal antibody in a standardized ELISA method gave a test ten times more sensitive than previously reported for P. falciparum sporozoites and its detection limit was less than 100 sporozoites per mosquito.

Original languageEnglish (US)
Pages (from-to)39-45
Number of pages7
JournalBulletin of the World Health Organization
Volume65
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

Sporozoites
Plasmodium falciparum
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Antibodies
Culicidae
Limit of Detection

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health

Cite this

Wirtz, R. A., Zavala, F. P., Charoenvit, Y., Campbell, G. H., Burkot, T. R., Schneider, I., ... Andre, R. G. (1987). Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. Bulletin of the World Health Organization, 65(1), 39-45.

Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. / Wirtz, R. A.; Zavala, Fidel P; Charoenvit, Y.; Campbell, G. H.; Burkot, T. R.; Schneider, I.; Esser, K. M.; Beaudoin, R. L.; Andre, R. G.

In: Bulletin of the World Health Organization, Vol. 65, No. 1, 1987, p. 39-45.

Research output: Contribution to journalArticle

Wirtz, RA, Zavala, FP, Charoenvit, Y, Campbell, GH, Burkot, TR, Schneider, I, Esser, KM, Beaudoin, RL & Andre, RG 1987, 'Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development', Bulletin of the World Health Organization, vol. 65, no. 1, pp. 39-45.
Wirtz, R. A. ; Zavala, Fidel P ; Charoenvit, Y. ; Campbell, G. H. ; Burkot, T. R. ; Schneider, I. ; Esser, K. M. ; Beaudoin, R. L. ; Andre, R. G. / Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development. In: Bulletin of the World Health Organization. 1987 ; Vol. 65, No. 1. pp. 39-45.
@article{21a3466be94c425da0a7f74edd36e9ce,
title = "Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development",
abstract = "Ten monoclonal antibodies developed against Plasmodium falciparum sporozoites at four institutions were evaluated for use in an enzyme-linked immunosorbent assay (ELISA). Four of the antibodies were eliminated because of their low sensitivity or requirement for high concentrations of capture antibody, while an additional four were rejected because they exhibited cross-reactivity with P. berghei sporozoites. Of the two remaining monoclonal antibodies, that designated 2A10 had the highest sensitivity, a requirement for lower concentrations of capture antibody, and had been tested successfully against sporozoites from a wider range of geographical areas than the others. Use of this monoclonal antibody in a standardized ELISA method gave a test ten times more sensitive than previously reported for P. falciparum sporozoites and its detection limit was less than 100 sporozoites per mosquito.",
author = "Wirtz, {R. A.} and Zavala, {Fidel P} and Y. Charoenvit and Campbell, {G. H.} and Burkot, {T. R.} and I. Schneider and Esser, {K. M.} and Beaudoin, {R. L.} and Andre, {R. G.}",
year = "1987",
language = "English (US)",
volume = "65",
pages = "39--45",
journal = "Bulletin of the World Health Organization",
issn = "0042-9686",
publisher = "World Health Organization",
number = "1",

}

TY - JOUR

T1 - Comparative testing of monoclonal antibodies against Plasmodium falciparum sporozoites for ELISA development

AU - Wirtz, R. A.

AU - Zavala, Fidel P

AU - Charoenvit, Y.

AU - Campbell, G. H.

AU - Burkot, T. R.

AU - Schneider, I.

AU - Esser, K. M.

AU - Beaudoin, R. L.

AU - Andre, R. G.

PY - 1987

Y1 - 1987

N2 - Ten monoclonal antibodies developed against Plasmodium falciparum sporozoites at four institutions were evaluated for use in an enzyme-linked immunosorbent assay (ELISA). Four of the antibodies were eliminated because of their low sensitivity or requirement for high concentrations of capture antibody, while an additional four were rejected because they exhibited cross-reactivity with P. berghei sporozoites. Of the two remaining monoclonal antibodies, that designated 2A10 had the highest sensitivity, a requirement for lower concentrations of capture antibody, and had been tested successfully against sporozoites from a wider range of geographical areas than the others. Use of this monoclonal antibody in a standardized ELISA method gave a test ten times more sensitive than previously reported for P. falciparum sporozoites and its detection limit was less than 100 sporozoites per mosquito.

AB - Ten monoclonal antibodies developed against Plasmodium falciparum sporozoites at four institutions were evaluated for use in an enzyme-linked immunosorbent assay (ELISA). Four of the antibodies were eliminated because of their low sensitivity or requirement for high concentrations of capture antibody, while an additional four were rejected because they exhibited cross-reactivity with P. berghei sporozoites. Of the two remaining monoclonal antibodies, that designated 2A10 had the highest sensitivity, a requirement for lower concentrations of capture antibody, and had been tested successfully against sporozoites from a wider range of geographical areas than the others. Use of this monoclonal antibody in a standardized ELISA method gave a test ten times more sensitive than previously reported for P. falciparum sporozoites and its detection limit was less than 100 sporozoites per mosquito.

UR - http://www.scopus.com/inward/record.url?scp=0023273782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023273782&partnerID=8YFLogxK

M3 - Article

C2 - 3555879

AN - SCOPUS:0023273782

VL - 65

SP - 39

EP - 45

JO - Bulletin of the World Health Organization

JF - Bulletin of the World Health Organization

SN - 0042-9686

IS - 1

ER -